Peptide therapy for diabetes in NOD mice

The Lancet

Volumn 343, Issue 8899, 1994, Pages 704-706

  Elias, D ^a   Cohen, I R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; P277; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0028215907     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)91582-2     Document Type: Article

References (10)

1. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat
2. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: requirement for both L3T4 + and Ly + 2 + T cells
3. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
4. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65 kDa heat shock protein
5. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus
6. Immunocytochemical localization of heat-shock protein 60-related protein in beta-cell secretory granules and its altered distribution in non-obese diabetic mice
7. Anti-idiotypic network induced by T cell vaccination against EAE
8. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination
9. The cognitive principle challenges clonal selection
10. The cognitive paradigm and the immunological homunculus